Although IL-5 level and depression severity was not significantly associated in different groups, based on the moderation analysis, the differential association between IL-5 levels and depression severity between breast cancer groups receiving (regression coefficient = 0.66) and not receiving chemotherapy (regression coefficient = − 0.97) was 1.59 of regression coefficient (Fig. 1). Here, IL5 is linked to depressive symptom measurement.